23STRANDS

23Strands is a wholly Australian owned startup focused on delivering truly personalised healthcare. Our team is dedicated to utilising whole genome sequencing and Artificial Intelligence to unlock the power of your genetic code. We combine deep phenotype and other diagnostic pathology to provide a more accurate pathway to better patient outcomes. Since 2018, 23Strands has developed a proven capability to deliver genome-wide DNA sequencing data to allow a more accurate understanding of complex diseases and to facilitate improvements in patient care... 23Strands is pleased to be announcing its strategic IVF research partnership and our success with securing a $3 million federal government MRFF grant, for a world-first AI IVF study with our research partners Monash University and Virtus Health.

Primary location: Pyrmont United States